-
Product Insights
Shigo Kas
Shigo Kas is a Hydro project located in Khyber Pakhtunkhwa, Pakistan. The project is owned and being developed by SaifCo Hydropower Ltd. The project is at the permitting stage. Empower your strategies with our Shigo Kas report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the report may be...
-
Product Insights
Budhi Gandaki Ka
Budhi Gandaki Ka is a Hydro project located in Gandaki, Nepal. The project is owned and being developed by KVR Group. The project is at the permitting stage. Empower your strategies with our Budhi Gandaki Ka report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the report may be...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – KA-2507 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - KA-2507 in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. KA-2507 in Solid Tumor Drug Details: KA-2507 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – AMG-305 in Malignant Mesothelioma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - AMG-305 in Malignant Mesothelioma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. AMG-305 in Malignant Mesothelioma Drug Details: Monoclonal antibody is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Durvalumab in Mycosis Fungoides
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Durvalumab in Mycosis Fungoides report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Durvalumab in Mycosis Fungoides Drug Details: Durvalumab (MEDI-4736, Imfinzi, Fidursi, Imfinzio) a...
-
Product Insights
X-Ray Systems Pipeline by Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies
X-Ray Systems Pipeline Market Report Overview X-ray systems use high-energy radiation to diagnose diseases. The X-Ray Systems pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials. Key Segments · Direct Digital Radiography (DDR) X-ray Systems · Flat Panel...
-
Product Insights
Longi Ningxia Solar PV Park
Longi Ningxia Solar PV Park is a solar PV project located in Ningxia, China. The project is owned by China Energy Engineering Corp Ltd and is developed by Ningxia Zhongke Ka New Energy Research Institute Co Ltd. The project is currently under construction. Empower your strategies with our Longi Ningxia Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Ucenprubart in Autoimmune Disorders
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Ucenprubart in Autoimmune Disorders report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Ucenprubart in Autoimmune DisordersDrug Details: Ucenprubart (LY-3454738) is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – INCB-86550 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - INCB-86550 in Solid Tumor report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.INCB-86550 in Solid Tumor Drug Details:INCB-86550 is under development for the treatment of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – BXQ-350 in Pancreatic Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - BXQ-350 in Pancreatic Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.BXQ-350 in Pancreatic Cancer Drug Details:BXQ-350 is under development for the treatment of...